| Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nature medicine 26 (3), 387-397, 2020 | 634 | 2020 |
| Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ... The Lancet Neurology 20 (9), 739-752, 2021 | 358 | 2021 |
| 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases DN Soleimani-Meigooni, L Iaccarino, R La Joie, S Baker, V Bourakova, ... Brain 143 (11), 3477-3494, 2020 | 127 | 2020 |
| Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET R La Joie, AV Visani, OH Lesman-Segev, SL Baker, L Edwards, ... Neurology 96 (5), e650-e661, 2021 | 104 | 2021 |
| Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab L VandeVrede, DM Gibbs, M Koestler, R La Joie, PA Ljubenkov, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 84 | 2020 |
| Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators. Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and … EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nat Med 26 (3), 387-397, 2020 | 74 | 2020 |
| Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer’s disease KG Ranasinghe, P Verma, C Cai, X Xie, K Kudo, X Gao, H Lerner, ... Elife 11, e77850, 2022 | 72 | 2022 |
| Plasma glial fibrillary acidic protein levels differ along the spectra of amyloid burden and clinical disease stage BM Asken, FM Elahi, R La Joie, A Strom, AM Staffaroni, CA Lindbergh, ... Journal of Alzheimer's Disease 78 (1), 265-276, 2020 | 71 | 2020 |
| Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease A Strom, L Iaccarino, L Edwards, OH Lesman-Segev, ... Brain 145 (2), 713-728, 2022 | 66 | 2022 |
| Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease JA Tanner, L Iaccarino, L Edwards, BM Asken, ML Gorno-Tempini, ... Brain 145 (12), 4489-4505, 2022 | 47 | 2022 |
| Spatial relationships between molecular pathology and neurodegeneration in the Alzheimer’s disease continuum L Iaccarino, R La Joie, L Edwards, A Strom, DR Schonhaut, ... Cerebral Cortex 31 (1), 1-14, 2021 | 44 | 2021 |
| Advancing Research and Treatment for Frontotemporal Lobar Degeneration investigators. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer’s … EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ... Lancet Neurol 20 (9), 739-752, 2021 | 43 | 2021 |
| Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females L Edwards, R La Joie, L Iaccarino, A Strom, SL Baker, KB Casaletto, ... Neurobiology of aging 105, 86-98, 2021 | 37 | 2021 |
| Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer’s disease E Singleton, O Hansson, YAL Pijnenburg, R La Joie, WG Mantyh, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (8), 872-880, 2021 | 25 | 2021 |
| BHA‐CS: a novel cognitive composite for Alzheimer's disease and related disorders E Tsoy, SJ Erlhoff, CA Goode, KA Dorsman, S Kanjanapong, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 24 | 2020 |
| Association of Plasma P-tau217 and P-tau181 with clinical phenotype, neuropathology, and imaging markers in Alzheimer’s disease and frontotemporal lobar degeneration: a … EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ... The Lancet. Neurology 20 (9), 739, 2021 | 18 | 2021 |
| Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts K Provost, L Iaccarino, DN Soleimani-Meigooni, S Baker, L Edwards, ... European journal of nuclear medicine and molecular imaging 48, 2259-2271, 2021 | 18 | 2021 |
| Treatment for frontotemporal lobar degeneration, diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nat Med 26 (3), 387-397, 2020 | 18 | 2020 |
| Association of remote mild traumatic brain injury with cortical amyloid burden in clinically normal older adults BM Asken, WG Mantyh, R La Joie, A Strom, KB Casaletto, AM Staffaroni, ... Brain imaging and behavior, 1-9, 2021 | 17 | 2021 |
| Detecting Alzheimer’s disease biomarkers with a brief tablet-based cognitive battery: sensitivity to Aβ and tau PET E Tsoy, A Strom, L Iaccarino, SJ Erlhoff, CA Goode, AM Rodriguez, ... Alzheimer's Research & Therapy 13, 1-10, 2021 | 13 | 2021 |
